Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes

2010100 citationsJournal Article

Authors

Timothy A. Sanborn · Lehigh Valley Hospital-Pocono

Ramin Ebrahimi · NorthShore University HealthSystem

Steven V. Manoukian · New York University

Brent McLaurin · NorthShore University HealthSystem

David A. Cox · University of California, Los Angeles

Frederick Feit · Université de Caen Normandie

Martial Hamon

Abstract

In patients with acute coronary syndromes undergoing an early invasive management strategy by the femoral approach, the use of a VCD, bivalirudin monotherapy, or both minimizes rates of major ASB. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique Identifier: NCT00093158.

Topics & Keywords

Acute Myocardial Infarction Research Vascular Procedures and Complications Venous Thromboembolism Diagnosis and Management

Publication Details

Published in: Circulation Cardiovascular Interventions

Volume 3, Issue 1, pp. 57-62

DOI: 10.1161/circinterventions.109.896704

Field-Weighted Citation Impact: 9.34

Command Palette

Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes

Authors

Abstract

Topics & Keywords

Publication Details